319 related articles for article (PubMed ID: 11333876)
21. Characterization of chimeras between the ecotropic Moloney murine leukemia virus and the amphotropic 4070A envelope proteins.
Peredo C; O'Reilly L; Gray K; Roth MJ
J Virol; 1996 May; 70(5):3142-52. PubMed ID: 8627794
[TBL] [Abstract][Full Text] [Related]
22. Two point mutations increase targeted transduction and stabilize vector association of a modified retroviral envelope protein.
Zavorotinskaya T; Albritton LM
Mol Ther; 2001 Mar; 3(3):323-8. PubMed ID: 11273774
[TBL] [Abstract][Full Text] [Related]
23. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry.
Kubo Y; Tominaga C; Yoshii H; Kamiyama H; Mitani C; Amanuma H; Yamamoto N
Arch Virol; 2007; 152(12):2169-82. PubMed ID: 17851730
[TBL] [Abstract][Full Text] [Related]
24. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles.
Schnierle BS; Moritz D; Jeschke M; Groner B
Gene Ther; 1996 Apr; 3(4):334-42. PubMed ID: 8732165
[TBL] [Abstract][Full Text] [Related]
25. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients.
Stitz J; Steidl S; Merget-Millitzer H; König R; Müller P; Nocken F; Engelstädter M; Bobkova M; Schmitt I; Kurth R; Buchholz CJ; Cichutek K
Virology; 2000 Feb; 267(2):229-36. PubMed ID: 10662618
[TBL] [Abstract][Full Text] [Related]
26. The effects of human serum and cerebrospinal fluid on retroviral vectors and packaging cell lines.
Russell DW; Berger MS; Miller AD
Hum Gene Ther; 1995 May; 6(5):635-41. PubMed ID: 7578400
[TBL] [Abstract][Full Text] [Related]
27. Effects of the gag region on genome stability: avian retroviral vectors that contain sequences from the Bryan strain of Rous sarcoma virus.
Federspiel MJ; Hughes SH
Virology; 1994 Sep; 203(2):211-20. PubMed ID: 8053145
[TBL] [Abstract][Full Text] [Related]
28. Transduction of human embryonic stem cells by ecotropic retroviral vectors.
Koch P; Siemen H; Biegler A; Itskovitz-Eldor J; Brüstle O
Nucleic Acids Res; 2006; 34(18):e120. PubMed ID: 16998181
[TBL] [Abstract][Full Text] [Related]
29. Partial sequence homology between retroviruses of various species in the C-terminal part of the env gene.
Drescher B; Möhring R; Winkler J; Nyakatura G; Rosenthal S
Folia Biol (Praha); 1985; 31(2):93-106. PubMed ID: 2991031
[TBL] [Abstract][Full Text] [Related]
30. Mutational library analysis of selected amino acids in the receptor binding domain of envelope of Akv murine leukemia virus by conditionally replication competent bicistronic vectors.
Bahrami S; Jespersen T; Pedersen FS; Duch M
Gene; 2003 Oct; 315():51-61. PubMed ID: 14557064
[TBL] [Abstract][Full Text] [Related]
31. Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols.
Farson D; McGuinness R; Dull T; Limoli K; Lazar R; Jalali S; Reddy S; Pennathur-Das R; Broad D; Finer M
J Gene Med; 1999; 1(3):195-209. PubMed ID: 10738568
[TBL] [Abstract][Full Text] [Related]
32. Construction and characterization of a replication-competent retroviral shuttle vector plasmid.
Oh J; Julias JG; Ferris AL; Hughes SH
J Virol; 2002 Feb; 76(4):1762-8. PubMed ID: 11799171
[TBL] [Abstract][Full Text] [Related]
33. Safe and efficient ecotropic and amphotropic packaging lines for use in gene transfer experiments.
Markowitz DG; Goff SP; Bank A
Trans Assoc Am Physicians; 1988; 101():212-8. PubMed ID: 3077729
[TBL] [Abstract][Full Text] [Related]
34. Characterization and comparison of avian and murine helper cell lines for production of replication-defective retroviruses for avian transformation.
Highkin MK; Krivi GG; Hippenmeyer PJ
Poult Sci; 1991 Apr; 70(4):970-81. PubMed ID: 1652135
[TBL] [Abstract][Full Text] [Related]
35. Host range restrictions of oncogenes: myc genes transform avian but not mammalian cells and mht/raf genes transform mammalian but not avian cells.
Li R; Zhou RP; Duesberg P
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7522-7. PubMed ID: 8755507
[TBL] [Abstract][Full Text] [Related]
36. Plasmoviruses: nonviral/viral vectors for gene therapy.
Noguiez-Hellin P; Meur MR; Salzmann JL; Klatzmann D
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4175-80. PubMed ID: 8633036
[TBL] [Abstract][Full Text] [Related]
37. Detection of ecotropic replication-competent retroviruses: comparison of s(+)/l(-) and marker rescue assays.
Reeves L; Duffy L; Koop S; Fyffe J; Cornetta K
Hum Gene Ther; 2002 Sep; 13(14):1783-90. PubMed ID: 12396630
[TBL] [Abstract][Full Text] [Related]
38. Replication-competent and -defective retrovirus vectors for oncogenic studies.
Samarut J; Flamant F; Heard JM
Methods Enzymol; 1995; 254():206-28. PubMed ID: 8531688
[No Abstract] [Full Text] [Related]
39. Tagging retrovirus vectors with a metal binding peptide and one-step purification by immobilized metal affinity chromatography.
Ye K; Jin S; Ataai MM; Schultz JS; Ibeh J
J Virol; 2004 Sep; 78(18):9820-7. PubMed ID: 15331716
[TBL] [Abstract][Full Text] [Related]
40. Efficient infection mediated by viral receptors incorporated into retroviral particles.
Balliet JW; Bates P
J Virol; 1998 Jan; 72(1):671-6. PubMed ID: 9420272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
